Łukasz Żukowski

Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism

A. Krętowski, M. Szelachowska, D. Lipińska, 2021, Journal of clinical medicine.

Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?

M. Górska, A. Grodzka, J. Myśliwiec, 2012, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Diagnostics of hypercortisolism - comparison between the clinical usefulness of salivary and serum cortisol measurements.

M. Górska, J. Myśliwiec, Łukasz Żukowski, 2013, Endokrynologia Polska.

Efficacy of 99mTc-DTPA SPECT/CT in diagnosing Orbitopathy in graves’ disease

A. Popławska-Kita, K. Siewko, P. Szumowski, 2019, BMC Endocrine Disorders.

Dosimetry during adjuvant 131I therapy in patients with differentiated thyroid cancer-clinical implications

A. Adamska, A. Krętowski, A. Popławska-Kita, 2021, Scientific Reports.

Enhancing the efficacy of 131I therapy in non-toxic multinodular goitre with appropriate use of methimazole: an analysis of randomized controlled study

A. Adamska, A. Krętowski, A. Popławska-Kita, 2019, Endocrine.

The Role of the CYP11B2 Promoter Polymorphism in the Diagnosis of Primary Aldosteronism

N. Wawrusiewicz-Kurylonek, P. Szumowski, M. Mojsak, 2020, Journal of clinical medicine.

Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine

A. Adamska, A. Krętowski, A. Popławska-Kita, 2021, Endocrine connections.

Pre-Processing Method for Contouring the Uptake Levels of [18F] FDG for Enhanced Specificity of PET Imaging of Solitary Hypermetabolic Pulmonary Nodules

E. Sierko, P. Szumowski, M. Mojsak, 2021, Journal of clinical medicine.